MedPath

The effect of Citicoline in major depressio

Phase 2
Conditions
Major depression.
Major Depressive episode
Registration Number
IRCT201502191556N74
Lead Sponsor
Tehran Medical Sciences University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

a age between 18 – 50 years old; diagnoses are done on the basis of Diagnostic &
Statistical Mental Disorders (DSMD); HRSD score above14; signing informed consent.
Exclusion criteria: demise of a close relative; having other psychocognitive affliction; taking antidepressive & psychoactive drugs within the last two months; heart complication; thyroid complication; history of ECT (Electroconvulsive Therapy); alcohol & drug addiction; reaching menopause age; pregnancy and lactation.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of depression. Timepoint: Assessment in first and on 2th, 4th and 6th weeks after onset of receiving medication. Method of measurement: Measurment by HAMD.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath